Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class III · Low risk Terminated Initiated Sep 16, 2015 (11 years ago)

UN1002 Air

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

CGMP Deviations: Confirmed customer compliant of odor when turning on a cylinder of medical air.

Cause type: cGMP deviation

Departures from current Good Manufacturing Practice found in production or during FDA inspection. A broad quality-system cause: the batch was made under conditions that fall short of FDA manufacturing standards. All cgmp deviation recalls.

What was recalled

UN1002 Air, Compressed, Breathing Grade, USP, Distributed by Praxair Distribution, Inc. Roseville, MN 55113, NDC 59579-006.

Affected NDC 59579-0006

Compare with the code on your package — it is the most precise check available.

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Air
NDC 59579-0006
1000 mL/L Gas
Respiratory (inhalation)
Linde Gas & Equipment Inc. Rx
Recalling firm
Praxair Inc.
Origin
CT, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0782-2016 · FDA notice

Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other recalls by Praxair Inc.

All 2015 recalls
Class III · Low risk

UN1002 Air

CGMP Deviations: Confirmed customer compliant of odor when turning on a cylinder of medical air.

Terminated cGMP deviation Praxair Inc. D-0783-2016

Other cgmp deviation recalls from 2015

All cgmp deviation recalls
Class II · Moderate risk

Oxygen

cGMP Deviations; trailer may not have met GMP requirements prior to filling

Terminated cGMP deviation AGA Gas Inc NDC 33237-001-01 D-0779-2016
Class II · Moderate risk

Repaskin 30

cGMP Deviations; product does not comply with cGMP requirements

Ongoing cGMP deviation Sesderma, SL NDC 63181-0010-1 D-0849-2016